MNPR
Monopar Therapeutics Inc
96.60$
+1.0%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +2.4% | +243.0% | -26.3% | +82.5% | +26.3% | +21.7% | -35.5% | -44.5% | +720.8% | +133.4% | |
| – | +3.3% | +335.8% | -19.9% | +80.8% | +27.0% | +22.2% | -35.8% | -44.3% | +722.2% | +133.0% | |
| – | +3.4% | +333.4% | -23.3% | +91.7% | +26.7% | +21.3% | -59.7% | -11.2% | +530.6% | +35.0% | |
| – | +3.4% | +333.4% | -23.3% | +91.7% | +26.7% | +21.3% | -35.4% | -44.6% | +728.7% | +133.2% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | -12.6% | +383.4% | +28.1% | +81.2% | +62.5% | +34.3% | +98.5% | -44.0% | +199.0% | -45.0% | |
| – | -12.6% | +383.4% | +28.1% | +81.2% | +62.5% | +34.3% | +98.0% | -43.8% | +199.0% | -47.9% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | -12.6% | +383.4% | +28.1% | +81.2% | +62.5% | +34.3% | +98.0% | -43.8% | +28.3% | +21.3% | |
| – | +2.8% | +239.8% | -28.1% | +82.5% | +24.3% | +20.7% | -46.7% | -44.6% | +885.0% | +150.4% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | +20.8% | +5.7% | +0.0% | +1.6% | +3.5% | +13.8% | +2.0% | +14.1% | -20.9% | -35.5% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.